Psychotherapy Remains the Best Treatment for Cannabis Dependence, With No Approved Medications
A review of randomized trials found cognitive behavioral therapy combined with other approaches had moderate to large effects on cannabis dependence, while no pharmacotherapy has been approved and serotonergic antidepressants may actually worsen withdrawal.
Quick Facts
What This Study Found
This evidence-based review of treatment options for cannabis dependence found psychotherapy to be the most effective approach, with all psychotherapeutic interventions supported at evidence level Ia (the highest).
Cognitive behavioral therapy (CBT) combined with other techniques showed moderate to large effects (Cohen's d = 0.53-0.9) on cannabis consumption, psychosocial functioning, and dependence severity. Systemic multidimensional family therapy was beneficial for younger adolescents with high use and psychiatric comorbidities. Motivational interviewing was effective for patients regardless of initial desire for abstinence.
For pharmacotherapy, gabapentin showed a weak effect (d = 0.26) on consumption and abstinence. Cannabinoid receptor antagonists alleviated withdrawal symptoms. Critically, serotonergic antidepressants were found to potentially worsen withdrawal and increase relapse likelihood.
Abstinence rates even with psychotherapy remained only moderate, highlighting the need for continued treatment development.
Key Numbers
CBT: effect size d = 0.53-0.9 (evidence level Ia). Gabapentin: d = 0.26 (evidence level Ib). Cannabinoid receptor antagonists for withdrawal: d = 0.223 and 0.481 (evidence level Ib). Serotonergic antidepressants: may worsen withdrawal.
How They Did This
Selective literature review of randomized controlled trials from PubMed and Cochrane databases, evaluating psychotherapeutic and pharmacological interventions for cannabis dependence. Evidence levels were assigned according to standard hierarchies.
Why This Research Matters
With cannabis use increasing globally and cannabis dependence now recognized as a clinical condition, practitioners need guidance on evidence-based treatments. This review provides a clear hierarchy: psychotherapy first, specific pharmacological adjuncts for withdrawal management, and a warning against using serotonergic antidepressants.
The Bigger Picture
Unlike opioid and alcohol dependence, which have FDA-approved pharmacotherapies, cannabis dependence lacks any approved medication. Psychotherapy is effective but produces only moderate abstinence rates. The field needs the kind of pharmacological innovation that transformed opioid and alcohol treatment.
What This Study Doesn't Tell Us
Selective rather than systematic review methodology. The evidence base for cannabis dependence treatment is smaller than for other substances. Many studies have small sample sizes and limited follow-up periods. The review was published in German, potentially limiting its reach.
Questions This Raises
- ?Could combinations of psychotherapy and pharmacotherapy produce better outcomes than either alone?
- ?Will the serotonergic antidepressant finding be confirmed in larger studies?
- ?Are newer compounds being tested for cannabis dependence treatment?
Trust & Context
- Key Stat:
- CBT showed moderate-to-large effects (d = 0.53-0.9) on cannabis dependence; no medication is approved.
- Evidence Grade:
- Strong evidence from a review of randomized controlled trials with clear evidence level assignments for each intervention.
- Study Age:
- Published in 2016. The cannabis dependence treatment landscape continues to evolve with ongoing clinical trials.
- Original Title:
- Evidence-based Treatment Options in Cannabis Dependency.
- Published In:
- Deutsches Arzteblatt international, 113(39), 653-659 (2016)
- Authors:
- Walther, Lisa, Gantner, Andreas, Heinz, Andreas(14), Majić, Tomislav
- Database ID:
- RTHC-01293
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What is the best treatment for cannabis addiction?
Cognitive behavioral therapy (CBT) combined with motivational interviewing has the strongest evidence, with moderate to large effect sizes. No medication has been approved for cannabis dependence. Gabapentin showed a small effect, and cannabinoid-based medications may help with withdrawal symptoms.
Can antidepressants help with quitting cannabis?
This review found that serotonergic antidepressants (SSRIs) may actually worsen cannabis withdrawal and increase relapse risk. This is an important caution for clinicians who might prescribe them to manage mood symptoms during cannabis cessation.
Read More on RethinkTHC
- 30-days-without-weed
- 420-sober-survival-guide
- 6-months-sober-weed-what-to-expect
- 90-days-no-weed
- CBT-cannabis-recovery
- benefits-of-quitting-weed
- boredom-after-quitting-weed
- boredom-after-quitting-weed-nothing-fun
- cannabis-dependence-physical-psychological-addiction-science
- cannabis-perception-vs-evidence-gap
- cannabis-relapse-cycle-pattern
- cannabis-use-disorder-test
- cold-turkey-vs-taper-quit-weed
- creativity-without-weed-quitting-artist-musician
- cross-addiction-quit-weed-start-drinking
- dating-sober-after-quitting-weed
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- help-someone-quit-weed
- hobbies-after-quitting-weed
- how-to-quit-weed
- identity-after-quitting-weed
- is-weed-addictive
- is-weed-addictive-science
- journaling-weed-withdrawal
- leaving-stoner-culture-identity
- marijuana-anonymous-SMART-recovery-compare
- meditation-mindfulness-weed-withdrawal
- money-saved-quitting-weed-calculator
- one-year-sober-weed
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-and-alcohol
- quitting-weed-creativity
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-face-changes-skin
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- quitting-weed-weight-loss-gain
- rehab-for-weed-addiction-necessary
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- should-i-quit-weed
- signs-of-cannabis-use-disorder
- sober-music-festival-concert-without-weed
- supplements-weed-withdrawal
- telling-friends-quitting-weed
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
- weed-vape-pen-addiction
- best-apps-quitting-weed-review
- best-apps-quit-weed-2026
- best-books-quitting-weed-cannabis-recovery
- support-groups-quit-weed
Cite This Study
https://rethinkthc.com/research/RTHC-01293APA
Walther, Lisa; Gantner, Andreas; Heinz, Andreas; Majić, Tomislav. (2016). Evidence-based Treatment Options in Cannabis Dependency.. Deutsches Arzteblatt international, 113(39), 653-659. https://doi.org/10.3238/arztebl.2016.0653
MLA
Walther, Lisa, et al. "Evidence-based Treatment Options in Cannabis Dependency.." Deutsches Arzteblatt international, 2016. https://doi.org/10.3238/arztebl.2016.0653
RethinkTHC
RethinkTHC Research Database. "Evidence-based Treatment Options in Cannabis Dependency." RTHC-01293. Retrieved from https://rethinkthc.com/research/walther-2016-evidencebased-treatment-options-in
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.